Precision Detection of FGFR2b Protein Expression in Solid Tumors
This investigation shows the importance of parameter screening approaches when evaluating FGFR2b across tumor types in immunohistochemistry to ensure optimal staining performance.
Authors
- Anne M. Wertheimer (ORCID: https://orcid.org/0000-0002-6627-4974)
- Bhavani B. Siddegowda
- Susan Marion
- Birte Aggeler
- Spencer Escobedo (ORCID: https://orcid.org/0000-0002-9026-9104)
- Steven P. Stratton (ORCID: https://orcid.org/0000-0003-1807-1248)
- John D. Palting
- Lisa Y. So
- Catherine Le
- Autumn Sky Watson
Institutions
- Roche (United States) (US)
- University of Arizona (US)
- Tucson Medical Center (US)
- Clinical Solutions (US)
Publication Details
- Journal
- Archives of Pathology & Laboratory Medicine
- Published
- 2025-05-06
- DOI
- https://doi.org/10.5858/arpa.2024-0497-oa
- Citations
- 1
- Primary Topic
- Fibroblast Growth Factor Research
- Type
- article
- Field-Weighted Citation Impact
- 0.81